Quadrant Capital Group LLC lowered its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 6.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 706 shares of the company’s stock after selling 48 shares during the period. Quadrant Capital Group LLC’s holdings in Henry Schein were worth $118,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in HSIC. YorkBridge Wealth Partners LLC raised its position in Henry Schein by 5.2% during the second quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock worth $104,000 after acquiring an additional 28 shares during the last quarter. Sun Life Financial INC raised its position in Henry Schein by 8,185.7% during the second quarter. Sun Life Financial INC now owns 580 shares of the company’s stock worth $106,000 after acquiring an additional 573 shares during the last quarter. Lee Financial Co acquired a new position in Henry Schein during the second quarter worth about $161,000. Acrospire Investment Management LLC raised its position in Henry Schein by 150.0% during the second quarter. Acrospire Investment Management LLC now owns 1,000 shares of the company’s stock worth $183,000 after acquiring an additional 600 shares during the last quarter. Finally, Van ECK Associates Corp raised its position in Henry Schein by 5.7% during the first quarter. Van ECK Associates Corp now owns 1,138 shares of the company’s stock worth $193,000 after acquiring an additional 61 shares during the last quarter. Institutional investors own 44.56% of the company’s stock.

HSIC has been the subject of a number of research reports. Credit Suisse Group restated a “hold” rating and set a $87.50 target price on shares of Henry Schein in a research report on Tuesday, August 29th. BidaskClub downgraded shares of Henry Schein from a “hold” rating to a “sell” rating in a report on Wednesday, August 2nd. Jefferies Group LLC reiterated a “hold” rating and set a $88.50 price target on shares of Henry Schein in a report on Thursday, September 28th. Morgan Stanley initiated coverage on shares of Henry Schein in a report on Thursday, September 21st. They set an “equal weight” rating and a $88.00 price target for the company. Finally, UBS AG reiterated a “buy” rating on shares of Henry Schein in a report on Friday, September 15th. One research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and six have given a buy rating to the company’s stock. Henry Schein presently has an average rating of “Hold” and a consensus target price of $92.14.

In related news, SVP Paul Rose sold 2,126 shares of the stock in a transaction that occurred on Wednesday, September 6th. The stock was sold at an average price of $172.51, for a total value of $366,756.26. Following the transaction, the senior vice president now owns 17,841 shares in the company, valued at $3,077,750.91. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.27% of the stock is owned by corporate insiders.

Henry Schein, Inc. (HSIC) traded up 0.470% during midday trading on Thursday, reaching $81.049. 128,112 shares of the company were exchanged. The firm’s 50-day moving average price is $83.08 and its 200 day moving average price is $87.43. The stock has a market capitalization of $12.81 billion, a price-to-earnings ratio of 23.685 and a beta of 1.08. Henry Schein, Inc. has a 52-week low of $73.12 and a 52-week high of $93.50.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, August 8th. The company reported $0.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.86 by $0.02. The business had revenue of $3.06 billion during the quarter, compared to analyst estimates of $3.05 billion. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The firm’s revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.82 earnings per share. Equities analysts predict that Henry Schein, Inc. will post $3.64 earnings per share for the current year.

Henry Schein declared that its Board of Directors has approved a stock repurchase plan on Monday, September 18th that authorizes the company to buyback $400.00 million in outstanding shares. This buyback authorization authorizes the company to reacquire up to 6.3% of its stock through open market purchases. Stock buyback plans are usually an indication that the company’s leadership believes its stock is undervalued.

TRADEMARK VIOLATION WARNING: “Quadrant Capital Group LLC Cuts Holdings in Henry Schein, Inc. (HSIC)” was published by Daily Political and is the sole property of of Daily Political. If you are accessing this article on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The correct version of this article can be read at https://www.dailypolitical.com/2017/10/12/quadrant-capital-group-llc-cuts-holdings-in-henry-schein-inc-hsic.html.

About Henry Schein

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.